![The exhale podcast, brought to you by Vitalograph](https://mcdn.podbean.com/mf/web/b835gd/Podcast-Banner2.jpg)
Episodes
![Episode # 52 Trikafta and Me](https://pbcdn1.podbean.com/imglogo/image-logo/6806711/Podcast-Profile-Image_1_dyfvkq_300x300.png)
Wednesday Jul 19, 2023
Episode # 52 Trikafta and Me
Wednesday Jul 19, 2023
Wednesday Jul 19, 2023
Annaka Haynes is a nursing student who has had Cystic Fibrosis since she was 6 weeks old. Trikafta developed by Vertex Pharmaceuticals was first approved by the FDA on October 21, 2019. This treatment is a triple combination regimen for cystic fibrosis patients starting at ages 2 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive to Trikafta based on in vitro data.
Version: 20240320
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.